Stock TQR BEIJING TONG REN TANG CHINESE MEDICINE COMPANY LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Company Beijing Tong Ren Tang Chinese Medicine Company Limited Deutsche Boerse AG

Equities

TQR

HK0000145638

Pharmaceuticals

Market Closed - Deutsche Boerse AG
Other stock markets
 11:41:40 31/05/2024 am IST 		5-day change 1st Jan Change
1.13 EUR +0.89% Intraday chart for Beijing Tong Ren Tang Chinese Medicine Company Limited -.--% -18.71%
13/05 Tong Ren Tang Chinese Medicine Appoints CEO MT
10/05 Beijing Tong Ren Tang Chinese Medicine Company Limited Appoints Wang Chi as an Executive Director and a Member of the Competition Executive Committee CI

Business Summary

Beijing Tong Ren Tang Chinese Medicine Company Limited is a company mainly engaged in the manufacturing and sale of Chinese medicine. Along with subsidiaries, it operates its business through three segments. The Hong Kong segment engages in the sale of Chinese medicine products and healthcare products and provision of Chinese medical consultation and treatments through retail outlets as well as wholesale of Chinese medicine products in Hong Kong. It is also involved in the royalty fee income from overseas entities using the brand of Tong Ren Tang. The Mainland China segment engages in the wholesale of healthcare products in Mainland China and the sole distribution of Tong Ren Tang branded products of Tong Ren Tang Technologies and Tong Ren Tang Ltd. to customers outside Mainland China. The Overseas segment engages in the retail and wholesale of Chinese medicine products and healthcare products and the provision of Chinese medical consultation and treatments in other overseas countries.

Number of employees: 798

Sales per Business

HKD in Million2022Weight2023Weight Delta
Chinese Medicine and Healthcare Products
96.6 %
1,682 97.2 % 1,474 96.6 % -12.36%
Service
3.3 %
49 2.8 % 51 3.3 % +4.48%
Royalty
0.0 %
1 0.0 % 0 0.0 % -46.33%

Sales per region

HKD in Million2022Weight2023Weight Delta
Hong Kong
60.0 %
826 47.7 % 915 60.0 % +10.81%
Overseas
31.5 %
472 27.2 % 480 31.5 % +1.84%
China
8.5 %
433 25.0 % 129 8.5 % -70.16%

Managers

Managers TitleAgeSince
Fung Yi Tsang DFI
 Director of Finance/CFO 48 01/12/01
Xia Li CTO
 Chief Tech/Sci/R&D Officer 54 01/08/01
Fei Chen BRD
 Director/Board Member 53 -

Members of the board

Members of the board TitleAgeSince
Ngai Chi Chan BRD
 Director/Board Member 52 15/13/15
Hai Ou Gu CHM
 Chairman 58 13/12
Yok Sing Tsang BRD
 Director/Board Member 76 12/17/12
Fei Chen BRD
 Director/Board Member 53 -
Li Feng BRD
 Director/Board Member 48 12/22/12
Hong Xi Xu BRD
 Director/Board Member 62 13/23/13

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 837,100,000 236,317,000 ( 28.23 %) 0 28.23 %

Shareholders

NameEquities%Valuation
TONG REN TANG TECHNOLOGIES CO. LTD.
38.05 %
318,540,000 38.05 % 390 M €
BEIJING TONGRENTANG CO., LTD
33.62 %
281,460,000 33.62 % 344 M €
Value Partners Ltd.
3.122 %
26,134,000 3.122 % 32 M €
China Merchants Fund Management Co., Ltd.
0.7440 %
6,228,000 0.7440 % 8 M €
Bosera Asset Management Co., Ltd.
0.2340 %
1,959,000 0.2340 % 2 M €
RAM Active Investments SA
0.1119 %
937,000 0.1119 % 1 M €
Manulife Investment Management (Hong Kong) Ltd.
0.1076 %
901,000 0.1076 % 1 M €
China Southern Asset Management Co., Ltd.
0.1052 %
881,000 0.1052 % 1 M €
AllianceBernstein Ltd.
0.0824 %
690,000 0.0824 % 844 284 €
Franklin Templeton Sealand Fund Management Co., Ltd.
0.0732 %
613,000 0.0732 % 750 067 €

Company contact information

Beijing Tong Ren Tang Chinese Medicine Co., Ltd.

Room 1405-1409, Office Tower Convention Plaza, 1 Harbour Road

, Hong Kong

+

http://www.cm.tongrentang.com
address Beijing Tong Ren Tang Chinese Medicine Company Limited(TQR)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Beijing Tong Ren Tang Chinese Medicine Company Limited

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
9.57 HKD
Average target price
13.92 HKD
Spread / Average Target
+45.51%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+40.73% 739B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+32.83% 598B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.30% 353B
MERCK & CO., INC. Stock Merck & Co., Inc.
+15.15% 318B
ABBVIE INC. Stock AbbVie Inc.
+4.05% 285B
ASTRAZENECA PLC Stock AstraZeneca PLC
+15.00% 240B
ROCHE HOLDING AG Stock Roche Holding AG
-5.52% 206B
AMGEN INC. Stock Amgen Inc.
+6.17% 164B
PFIZER, INC. Stock Pfizer, Inc.
-0.45% 162B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 3613 Stock
  4. TQR Stock
  5. Company Beijing Tong Ren Tang Chinese Medicine Company Limited